Follow
brian dynlacht
brian dynlacht
NYU School of Medicine
Verified email at med.nyu.edu
Title
Cited by
Cited by
Year
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ...
Cell Death & Differentiation 25 (3), 486-541, 2018
60892018
Inhibition of cyclin-dependent kinases by p21.
JW Harper, SJ Elledge, K Keyomarsi, B Dynlacht, LH Tsai, P Zhang, ...
Molecular biology of the cell 6 (4), 387-400, 1995
14011995
E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints
B Ren, H Cam, Y Takahashi, T Volkert, J Terragni, RA Young, ...
Genes & development 16 (2), 245-256, 2002
13712002
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
L Galluzzi, BS Pedro, I Vitale, SA Aaronson, JM Abrams, D Adam, ...
Cell Death & Differentiation 22 (1), 58-73, 2015
11922015
XBP1 controls diverse cell type-and condition-specific transcriptional regulatory networks
D Acosta-Alvear, Y Zhou, A Blais, M Tsikitis, NH Lents, C Arias, ...
Molecular cell 27 (1), 53-66, 2007
10272007
Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms
R Margueron, G Li, K Sarma, A Blais, J Zavadil, CL Woodcock, ...
Molecular cell 32 (4), 503-518, 2008
10202008
Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation
BD Dynlacht, T Hoey, R Tjian
Cell 66 (3), 563-576, 1991
9681991
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
L Galluzzi, SA Aaronson, J Abrams, ES Alnemri, DW Andrews, ...
Cell Death & Differentiation 16 (8), 1093-1107, 2009
8572009
Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression
Y Takahashi, JB Rayman, BD Dynlacht
Genes & development 14 (7), 804-816, 2000
8302000
Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators
T Hoey, ROJ Weinzierl, G Gill, JL Chen, BD Dynlacht, R Tjian
Cell 72 (2), 247-260, 1993
7651993
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
J Koh, GH Enders, B David Dynlacht, ED Harlow
Nature 375 (6531), 506-510, 1995
7101995
Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation.
K Helin, CL Wu, AR Fattaey, JA Lees, BD Dynlacht, C Ngwu, E Harlow
Genes & development 7 (10), 1850-1861, 1993
6201993
Cdk-activating kinase complex is a component of human transcription factor TFIIH
R Shiekhattar, F Mermelstein, RP Fisher, R Drapkin, B Dynlacht, ...
Nature 374 (6519), 283-287, 1995
5481995
An initial blueprint for myogenic differentiation
A Blais, M Tsikitis, D Acosta-Alvear, R Sharan, Y Kluger, BD Dynlacht
Genes & development 19 (5), 553-569, 2005
5422005
Differential regulation of E2F transactivation by cyclin/cdk2 complexes.
BD Dynlacht, O Flores, JA Lees, E Harlow
Genes & development 8 (15), 1772-1786, 1994
5401994
Cep97 and CP110 suppress a cilia assembly program
A Spektor, WY Tsang, D Khoo, BD Dynlacht
Cell 130 (4), 678-690, 2007
5222007
Cyclin-binding motifs are essential for the function of p21CIP1
J Chen, P Saha, S Kornbluth, BD Dynlacht, A Dutta
Molecular and cellular biology, 1996
4711996
Emerging roles for E2F: beyond the G1/S transition and DNA replication
H Cam, BD Dynlacht
Cancer cell 3 (4), 311-316, 2003
4492003
Regulating the transition from centriole to basal body
T Kobayashi, BD Dynlacht
Journal of Cell Biology 193 (3), 435-444, 2011
3982011
A common set of gene regulatory networks links metabolism and growth inhibition
H Cam, E Balciunaite, A Blais, A Spektor, RC Scarpulla, R Young, ...
Molecular cell 16 (3), 399-411, 2004
3982004
The system can't perform the operation now. Try again later.
Articles 1–20